CADTH | Evidence Driven
CADTH | Evidence Driven

Off-Label Use of Intravenous Immunoglobulin for Dermatological Conditions: Clinical Effectiveness

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1153-000

Question


  1. What is the clinical effectiveness of the off-label use of intravenous or subcutaneous immunoglobulin for the treatment of dermatological conditions?


Key Message

Twenty-one systematic reviews and meta-analyses and five randomized controlled trials were identified regarding the clinical effectiveness of the off-label use of intravenous or subcutaneous immunoglobulin for the treatment of dermatological conditions.


Files

Off-Label Use of Intravenous Immunoglobulin for Dermatological Conditions: Clinical Effectiveness Rapid Response November 3, 2017 View PDF

Related Content

Last Updated : November 3, 2017